- Home
- POWW vs VIGL Comparison
POWW vs VIGL Comparison
Compare POWW & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- VIGL
- Stock Information
- Founded
- POWW 1990
- VIGL 2020
- Country
- POWW United States
- VIGL United States
- Employees
- POWW N/A
- VIGL N/A
- Industry
- POWW Ordnance And Accessories
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- POWW Industrials
- VIGL Health Care
- Exchange
- POWW Nasdaq
- VIGL Nasdaq
- Market Cap
- POWW 154.4M
- VIGL 141.5M
- IPO Year
- POWW N/A
- VIGL 2022
- Fundamental
- Price
- POWW $1.28
- VIGL $3.19
- Analyst Decision
- POWW Hold
- VIGL Buy
- Analyst Count
- POWW 1
- VIGL 5
- Target Price
- POWW $1.50
- VIGL $16.80
- AVG Volume (30 Days)
- POWW 766.6K
- VIGL 51.8K
- Earning Date
- POWW 11-29-2024
- VIGL 11-07-2024
- Dividend Yield
- POWW N/A
- VIGL N/A
- EPS Growth
- POWW N/A
- VIGL N/A
- EPS
- POWW N/A
- VIGL N/A
- Revenue
- POWW $135,498,023.00
- VIGL N/A
- Revenue This Year
- POWW $5.67
- VIGL N/A
- Revenue Next Year
- POWW $4.86
- VIGL N/A
- P/E Ratio
- POWW N/A
- VIGL N/A
- Revenue Growth
- POWW N/A
- VIGL N/A
- 52 Week Low
- POWW $1.08
- VIGL $2.47
- 52 Week High
- POWW $2.94
- VIGL $6.06
- Technical
- Relative Strength Index (RSI)
- POWW 52.33
- VIGL 41.48
- Support Level
- POWW $1.16
- VIGL $2.89
- Resistance Level
- POWW $1.34
- VIGL $3.26
- Average True Range (ATR)
- POWW 0.09
- VIGL 0.23
- MACD
- POWW 0.01
- VIGL -0.06
- Stochastic Oscillator
- POWW 63.16
- VIGL 25.64
About POWW AMMO Inc.
AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.